Targeted Nuclear Imaging of Breast Cancer: Status of Radiotracer Development and Clinical Applications
Authors:
- 1 March 2012
- journal article
- review article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 27 (2) , 105-112
Abstract
Breast cancer is the most common cancer in women worldwide. Molecular imaging plays an important role in breast cancer diagnosis, staging, and treatment response evaluation. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are the main clinical molecular imaging modalities that are based on the detection of radiotracers. This article discusses the typical radiotracers used for breast cancer imaging by PET and SPECT. In addition, radiotracers that are currently applied for human breast cancer imaging or under clinical trials are also reviewed in compliance with the categories of tumor-specific targets to which they are aimed at.Keywords
This publication has 53 references indexed in Scilit:
- Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniquesEuropean Journal of Surgical Oncology, 2010
- Imaging of tumor glucose utilization with positron emission tomographyCancer and Metastasis Reviews, 2008
- Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancerAnnals of Oncology, 2008
- FDG PET/CT for the Detection and Evaluation of Breast Diseases: Usefulness and LimitationsRadioGraphics, 2007
- Detection of Bone Metastases in Breast Cancer by Positron Emission TomographyRadiologic Clinics of North America, 2007
- Usefulness of Scintimammography With Tc-99m MIBI in Clinical PracticeClinical Nuclear Medicine, 2006
- Biological characterisation of breast cancer by means of PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Technetium-99m sestamibi: an indicator of breast cancer invasivenessEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Clinical Experience with Tc-99m MIBI Imaging in Patients with Malignant Tumors Preliminary Results and Comparison with TI-201Clinical Nuclear Medicine, 1992